NO20052999L - Ny synergistisk kombinasjon omfattende roflumilast og formoterol - Google Patents

Ny synergistisk kombinasjon omfattende roflumilast og formoterol

Info

Publication number
NO20052999L
NO20052999L NO20052999A NO20052999A NO20052999L NO 20052999 L NO20052999 L NO 20052999L NO 20052999 A NO20052999 A NO 20052999A NO 20052999 A NO20052999 A NO 20052999A NO 20052999 L NO20052999 L NO 20052999L
Authority
NO
Norway
Prior art keywords
formoterol
combination including
synergistic combination
new synergistic
roflumilast
Prior art date
Application number
NO20052999A
Other languages
English (en)
Other versions
NO334247B1 (no
Inventor
Norbert Kolassa
Rolf Beume
Degenhard Marx
Daniela Bundschuh
Christian Weimar
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of NO20052999L publication Critical patent/NO20052999L/no
Publication of NO334247B1 publication Critical patent/NO334247B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen vedrører den kombinerte administtasjon av roflumilast og formoterol for behandlingen av lidelser i det respiratoriske system.
NO20052999A 2002-11-27 2005-06-17 Medikament omfattende roflumilast i kombinasjon med formoterol NO334247B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026505 2002-11-27
PCT/EP2003/013275 WO2004047829A1 (en) 2002-11-27 2003-11-26 New synergistic combination comprising roflumilast and formoterol

Publications (2)

Publication Number Publication Date
NO20052999L true NO20052999L (no) 2005-06-17
NO334247B1 NO334247B1 (no) 2014-01-20

Family

ID=32338002

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052999A NO334247B1 (no) 2002-11-27 2005-06-17 Medikament omfattende roflumilast i kombinasjon med formoterol

Country Status (31)

Country Link
US (1) US20060142308A1 (no)
EP (1) EP1567139B1 (no)
JP (1) JP2006508994A (no)
KR (1) KR101071798B1 (no)
CN (1) CN100346777C (no)
AT (1) ATE399543T1 (no)
AU (1) AU2003292120B2 (no)
BR (1) BR0316451A (no)
CA (1) CA2506962C (no)
CO (1) CO5690570A2 (no)
CY (1) CY1110369T1 (no)
DE (1) DE60321953D1 (no)
DK (1) DK1567139T3 (no)
EA (1) EA009935B1 (no)
ES (1) ES2309357T3 (no)
HR (1) HRP20050579B1 (no)
IL (1) IL168308A (no)
IS (1) IS2575B (no)
MA (1) MA27539A1 (no)
ME (1) ME00489B (no)
MX (1) MXPA05005437A (no)
NO (1) NO334247B1 (no)
NZ (1) NZ540659A (no)
PL (1) PL216752B1 (no)
PT (1) PT1567139E (no)
RS (1) RS51081B (no)
SI (1) SI1567139T1 (no)
TN (1) TNSN05131A1 (no)
UA (1) UA83018C2 (no)
WO (1) WO2004047829A1 (no)
ZA (1) ZA200503308B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
ES2443342T3 (es) * 2006-07-05 2014-02-19 Takeda Gmbh Combinación de inhibidor de la HMG-CoA reductasa rosuvastatina con un inhibidor de la fosfodiesterasa 4, tal como roflumilast, roflumilast-N-óxido para el tratamiento de enfermedades pulmonares inflamatorias
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
US20130172303A1 (en) * 2012-01-03 2013-07-04 Forest Laboratories Holdings Ltd. Roflumilast compositions for the treatment of copd
HUE052275T2 (hu) * 2013-01-28 2021-04-28 Incozen Therapeutics Pvt Ltd Eljárások autoimmun, légzõszervi és gyulladásos rendellenességek kezelésére roflumilaszt N-oxid inhalálásával
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
DE59410119D1 (de) * 1993-07-02 2002-06-20 Byk Gulden Lomberg Chem Fab Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
AU734122B2 (en) * 1997-02-17 2001-06-07 Takeda Gmbh Compositions for the treatment of ARDS or IRDS containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4- (difluoromethoxy)benzamide and lung surfactant
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
ES2302350T3 (es) * 1997-02-28 2008-07-01 Nycomed Gmbh Combinacion sinergica de inhibidores de pde y agonistas de adenilatociclasa o agonistas de guanililciclasa.
BR9913152A (pt) * 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
CA2715683A1 (en) * 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ES2296923T3 (es) * 2001-03-22 2008-05-01 Glaxo Group Limited Derivados formanilidas como agonistas del adrenorreceptor beta2.
KR100831534B1 (ko) * 2001-04-30 2008-05-22 글락소 그룹 리미티드 17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체

Also Published As

Publication number Publication date
TNSN05131A1 (en) 2007-05-14
WO2004047829A1 (en) 2004-06-10
BR0316451A (pt) 2005-10-11
CO5690570A2 (es) 2006-10-31
CY1110369T1 (el) 2015-04-29
WO2004047829A8 (en) 2005-06-30
NO334247B1 (no) 2014-01-20
ES2309357T3 (es) 2008-12-16
MXPA05005437A (es) 2005-08-03
HK1081861A1 (en) 2006-05-26
IS7898A (is) 2005-06-20
CN100346777C (zh) 2007-11-07
ATE399543T1 (de) 2008-07-15
NZ540659A (en) 2007-05-31
CA2506962A1 (en) 2004-06-10
KR20050085104A (ko) 2005-08-29
PL377732A1 (pl) 2006-02-06
EP1567139B1 (en) 2008-07-02
AU2003292120A1 (en) 2004-06-18
RS20050382A (sr) 2007-08-03
ZA200503308B (en) 2006-11-29
AU2003292120B2 (en) 2010-01-21
DK1567139T3 (da) 2008-11-03
CA2506962C (en) 2012-01-03
CN1713903A (zh) 2005-12-28
JP2006508994A (ja) 2006-03-16
PL216752B1 (pl) 2014-05-30
EP1567139A1 (en) 2005-08-31
HRP20050579A2 (hr) 2006-04-30
HRP20050579B1 (hr) 2014-01-31
MA27539A1 (fr) 2005-09-01
PT1567139E (pt) 2008-10-01
IS2575B (is) 2010-02-15
EA009935B1 (ru) 2008-04-28
US20060142308A1 (en) 2006-06-29
KR101071798B1 (ko) 2011-10-11
DE60321953D1 (de) 2008-08-14
UA83018C2 (uk) 2008-06-10
EA200500774A1 (ru) 2005-12-29
SI1567139T1 (sl) 2008-12-31
RS51081B (sr) 2010-10-31
ME00489B (me) 2011-10-10
IL168308A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
MXPA05006670A (es) Administracion de capsaicinoides.
DK1587506T3 (da) Administration af capsaicinoider
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
ATE320800T1 (de) Synergistische kombination von roflumilast und salmeterol
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
NO20052420L (no) Farmakologisk behandling av sovnapn±.
ATE447403T1 (de) Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
NO20064964L (no) Behandling av svekket respiratorisk funksjon
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
NO20053023L (no) Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol
NO20045344L (no) Kombinasjon for behandling av luftveisforstyrrelser

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ASTRAZENECA AB, SE

MM1K Lapsed by not paying the annual fees